BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17190622)

  • 1. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
    Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
    Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
    Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
    Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
    Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does imiquimod work in infantile hemangiomas?
    Czernik A; Bystryn JC
    J Am Acad Dermatol; 2007 Sep; 57(3):535; author reply 536. PubMed ID: 17707162
    [No Abstract]   [Full Text] [Related]  

  • 6. Involution of infantile haemangiomas after imiquimod 5% cream.
    Barry RB; Hughes BR; Cook LJ
    Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
    Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
    J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
    McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
    Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
    Hu L; Huang HZ; Li X; Lin XX; Li W
    Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.
    Mao XH; Wang JY; Yan JL
    J Zhejiang Univ Sci B; 2012 Sep; 13(9):745-50. PubMed ID: 22949365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
    Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
    Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
    Senchak AJ; Dann M; Cable B; Bessinger G
    Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
    Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
    Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerated infantile hemangioma treated with imiquimod.
    Mascarenhas R; Guiote V; Agro J; Henrique M
    Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.
    Craiglow BG; Antaya RJ
    Paediatr Drugs; 2013 Apr; 15(2):133-8. PubMed ID: 23456550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
    Blasi MA; Giammaria D; Balestrazzi E
    Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for infantile haemangioma: striking effect in the first weeks.
    Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.